Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Personalized monitoring of electrical remodelling during atrial fibrillation progression via remote transmissions from implantable devices.
Lillo-Castellano JM, González-Ferrer JJ, Marina-Breysse M, Martínez-Ferrer JB, Pérez-Álvarez L, Alzueta J, Martínez JG, Rodríguez A, Rodríguez-Pérez JC, Anguera I, Viñolas X, García-Alberola A, Quintanilla JG, Alfonso-Almazán JM, García J, Borrego L, Cañadas-Godoy V, Pérez-Castellano N, Pérez-Villacastín J, Jiménez-Díaz J, Jalife J, Filgueiras-Rama D. Lillo-Castellano JM, et al. Among authors: vinolas x. Europace. 2020 May 1;22(5):704-715. doi: 10.1093/europace/euz331. Europace. 2020. PMID: 31840163 Free PMC article.
Third-degree inter-atrial block and supraventricular tachyarrhythmias.
Bayés de Luna A, Guindo J, Viñolas X, Martinez-Rubio A, Oter R, Bayés-Genís A. Bayés de Luna A, et al. Among authors: vinolas x. Europace. 1999 Jan;1(1):43-6. doi: 10.1053/eupc.1998.0006. Europace. 1999. PMID: 11220539 No abstract available.
Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.
Ricci RP, Quesada A, Almendral J, Arribas F, Wolpert C, Adragao P, Zoni-Berisso M, Navarro X, DeSanto T, Grammatico A, Santini M; DATAS study Investigators. Ricci RP, et al. Europace. 2009 May;11(5):587-93. doi: 10.1093/europace/eup072. Europace. 2009. PMID: 19401341 Clinical Trial.
Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).
Mont L, Bisbal F, Hernández-Madrid A, Pérez-Castellano N, Viñolas X, Arenal A, Arribas F, Fernández-Lozano I, Bodegas A, Cobos A, Matía R, Pérez-Villacastín J, Guerra JM, Ávila P, López-Gil M, Castro V, Arana JI, Brugada J; SARA investigators. Mont L, et al. Among authors: vinolas x. Eur Heart J. 2014 Feb;35(8):501-7. doi: 10.1093/eurheartj/eht457. Epub 2013 Oct 17. Eur Heart J. 2014. PMID: 24135832 Free PMC article. Clinical Trial.
Clinical profile and incidence of ventricular arrhythmia in patients undergoing defibrillator generator replacement in Spain.
Fontenla A, López Gil M, Martínez Ferrer J, Alzueta J, Fernández Lozano I, Viñolas X, Rodríguez A, Fernández de la Concha J, Anguera I, Arribas F. Fontenla A, et al. Among authors: vinolas x. Rev Esp Cardiol (Engl Ed). 2014 Dec;67(12):986-92. doi: 10.1016/j.rec.2014.01.018. Epub 2014 Jun 2. Rev Esp Cardiol (Engl Ed). 2014. PMID: 25432708
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.
De Ferrari GM, Maier LS, Mont L, Schwartz PJ, Simonis G, Leschke M, Gronda E, Boriani G, Darius H, Guillamón Torán L, Savelieva I, Dusi V, Marchionni N, Quintana Rendón M, Schumacher K, Tonini G, Melani L, Giannelli S, Alberto Maggi C, Camm AJ; RAFFAELLO Investigators (see Online Supplementary Appendix for List of Participating Centers and Investigators). De Ferrari GM, et al. Heart Rhythm. 2015 May;12(5):872-8. doi: 10.1016/j.hrthm.2015.01.021. Epub 2015 Jan 17. Heart Rhythm. 2015. PMID: 25602175 Clinical Trial.
97 results